**Core Concept**
Etomidate is a short-acting intravenous anesthetic agent used for the induction of general anesthesia. It exerts its effects by acting on the GABA_A receptor, a chloride channel that is responsible for inhibiting neuronal excitability.

**Why the Correct Answer is Right**
Etomidate is known for its adrenal-suppressing effects, which are mediated by its inhibition of 11β-hydroxylase, an enzyme involved in the synthesis of cortisol from 11-deoxycortisol. This results in decreased production of cortisol and, consequently, an increase in adrenocorticotropic hormone (ACTH) levels. Etomidate also has a minimal effect on cardiovascular stability, making it a preferred choice for patients with cardiovascular disease.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because etomidate does not cause histamine release, which is a characteristic of other anesthetic agents such as propofol.

**Option B:** This option is incorrect because etomidate does not cause muscle rigidity, which is a side effect of succinylcholine.

**Option C:** This option is incorrect because etomidate does not cause respiratory depression, which is a characteristic of opioids such as fentanyl.

**Clinical Pearl / High-Yield Fact**
Etomidate is often used in patients with traumatic brain injury due to its ability to maintain cerebral perfusion pressure and prevent increases in intracranial pressure.

**Correct Answer: A. Etomidate does not cause histamine release.**